Next Article in Journal
Culture-Independent Single-Cell PacBio Sequencing Reveals Epibiotic Variovorax and Nucleus Associated Mycoplasma in the Microbiome of the Marine Benthic Protist Geleia sp. YT (Ciliophora, Karyorelictea)
Next Article in Special Issue
Yeast-Based Screening of Anti-Viral Molecules
Previous Article in Journal
Antimicrobial Resistance Risk Assessment of Vibrio parahaemolyticus Isolated from Farmed Green Mussels in Singapore
Previous Article in Special Issue
Targeted Mutations Produce Divergent Characteristics in Pedigreed Sake Yeast Strains
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Review

Utilization of Macroalgae for the Production of Bioactive Compounds and Bioprocesses Using Microbial Biotechnology

1
Laboratory of Natural Science, Faculty of Economics, Toyo University, Hakusan Bunkyo-ku, Tokyo 112-8606, Japan
2
Office of Society-Academia Collaboration for Innovation (SACI), Kyoto University, Yoshidahonmachi, Sakyo-ku, Kyoto 606-8501, Japan
*
Author to whom correspondence should be addressed.
Microorganisms 2023, 11(6), 1499; https://doi.org/10.3390/microorganisms11061499
Submission received: 31 March 2023 / Revised: 18 May 2023 / Accepted: 2 June 2023 / Published: 5 June 2023
(This article belongs to the Special Issue Trends in Yeast Biochemistry and Biotechnology)

Abstract

:
To achieve sustainable development, alternative resources should replace conventional resources such as fossil fuels. In marine ecosystems, many macroalgae grow faster than terrestrial plants. Macroalgae are roughly classified as green, red, or brown algae based on their photosynthetic pigments. Brown algae are considered to be a source of physiologically active substances such as polyphenols. Furthermore, some macroalgae can capture approximately 10 times more carbon dioxide from the atmosphere than terrestrial plants. Therefore, they have immense potential for use in the environment. Recently, macroalgae have emerged as a biomass feedstock for bioethanol production owing to their low lignin content and applicability to biorefinery processes. Herein, we provided an overview of the bioconversion of macroalgae into bioactive substances and biofuels using microbial biotechnology, including engineered yeast designed using molecular display technology.

1. Introduction

For many centuries, fossil fuel consumption has increased, leading to a high level of emissions of carbon dioxide into the atmosphere [1,2]. Moreover, human life relies on various materials produced via chemical synthesis using large amounts of energy. Recently, there has been an increase in energy demand in response to the growing global population and economy. Therefore, to pave the path to a sustainable future, it is critical we develop renewable and clean sources of bioenergy.
Bioethanol production has been proposed and developed using various agricultural biomasses, including corn [3], sugarcane [4], sugar beet [5], potato [6], and wheat [7]. Compared with fossil fuels, bioethanol produces fewer toxic substances and causes fewer harmful environmental issues [8]. However, concerns remain that the use of biomass for energy production competes with the use of food by humans and livestock. On the other hand, many biomolecules in macroalgae, including polysaccharides, can be converted to ethanol-fermentable sugars in ocean ecosystems. Therefore, macroalgae have attracted the attention of researchers as an alternative fuel source for bioethanol production. Macroalgae can grow at rates higher than those of terrestrial plants [9,10], and arable land is not needed for the cultivation or fertilization of macroalgae. Furthermore, macroalgae can grow in salt water, preventing competition for fresh water required for crop production in fields. Therefore, macroalgae are considered ideal resources for third-generation biofuels [11].
Algae are a group of photosynthetic, prokaryotic, and eukaryotic organisms [12]. Macroalgae come in different sizes and colors. They are classified according to their photosynthetic pigments, color schemes (red, brown, green, etc.), and habitat [9,13]. For example, the exclusive economic zone of Japan is approximately 450 million km2 (1/80 of the world’s total sea area), with >1000 macroalgal species in these limited areas. Furthermore, they have different chemical compositions and bioactive molecular contents.
Polysaccharides represent biomass or bioactive compounds. Brown algae commonly contain laminarin and fucoidan, green algae contain ulvans, and red algae contain large amounts of carrageenan [14]. Brown macroalgae additionally contain alginate, cellulose, hemicellulose, laminarin, and mannitol, which are the major carbohydrates (Figure 1) and are characterized by high contents of mannitol, laminarin, and alginate [15]. Laminarin comprises a β-1,3-linked glucose polymer with connecting β-1,6 cross-linked branches. In brown macroalgae, it functions as a long-term storage compound and exhibits seasonal variations ranging from 0 to 35% on a dry basis [16]. Brown macroalgae additionally contain mannitol as a carbon storage compound, accounting for up to 20–30% of the dry weight [17].
Bioactive compounds such as proteins and peptides in macroalgae exhibit anti-inflammatory, antioxidant, antitumor, antiviral, neuroprotective, hypocholesterolemic, hepatoprotective, and liver-protecting functions [18]. These beneficial health effects are also mediated by specific diterpenes, pigments (fucoxanthin, phycocyanin, and carotenoids), polysaccharides, and bioactive peptides [19]. In particular, phenolic compounds have the most structural variation and highest content in macroalgae. Phlorotannins are the most widely investigated polyphenols, with high contents in brown macroalgae [20].
In the present review, we describe bioactive compounds and biofuels from macroalgae using microbial technology. Furthermore, we emphasize the applications of recent microbial biotechnologies and molecular display technologies for biofuel production from macroalgae.

2. Biological Activity and Bioconversion of Green Macroalgae

2.1. Ulvan

The green macroalgae Ulva species are edible seaweeds comprising health-promoting and bioactive compounds. The major carbohydrates of Ulva species are ulvans and glucans, with median values of 45.0 mol% and 22.5 mol% for rhamnose and glucuronic acid, respectively. Ulvan accounts for 9–36% of the dry weight of Ulva species [21]. It is high in dietary fiber, thereby promoting gastrointestinal health, and is associated with a decrease in the occurrence of chronic diseases. Dutschei et al. reported that Bacillus licheniformis can grow on a medium containing ulvan-derived xylose-containing oligosaccharides [22]. Heterologous expression of two marine enzymes, namely, ulvan lyase PL28 and glucuronyl hydrolase GH105 [23], in Bacillus licheniformis resulted in the efficient conversion of the algal polysaccharide ulvan as a carbon and energy source [22]. In another study on the saccharification of ulvans, a broad-spectrum ulvan lyase was identified (Cdf7993 protein) from Formosa agariphila KMM 3901 and investigated further [24].

2.2. L-Rhamnose

Rhamnose is an important monosaccharide that is widely distributed among microorganisms and plants. Certain bacterial saponin glycans contain rhamnolipids, mycolic acids, and extracellular polysaccharides [25]. In the green macroalga Ulva lactuca, L-rhamnose and D-glucose are the major carbohydrates present in the ulvan polysaccharide structure; these sugars can be recovered under mild conditions [26].
Investigation of the antiviral activity of rhamnose polysaccharides revealed that rhamnose sulfate in the green alga Monostroma nitidum exhibits anti-severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) activity. SARS-CoV-2 invasion is achieved via the interaction of its S-protein with angiotensin-converting enzyme 2 (ACE2) in susceptible host cells. The rhamnose fraction not only inhibited the binding of S-protein and ACE2 analogs but also that of SARS-CoV-2 and ACE2 analogs [27]. In addition, branched and sulfated heterorhamnan exhibited specific activity against the herpes simplex virus [28]. Sulfated polysaccharides, including L-rhamnose derived from the green alga Spirogyra neglecta, exhibit immunomodulatory activity [29]. In addition to the immunomodulatory activity, several green algae exert antitumor activity [30]. A study reported that extracts containing sulfated heterorhamnans from the green alga Gayralia oxysperma exerted cytotoxic effects against U-87 MG, a cell line isolated from a patient with malignant gliomas. Furthermore, sulfated polysaccharides with rhamnose increased the number of cells in the G1 phase [31].
Clostridium beijerinckii can use L-rhamnose as the sole carbon source to produce acetic acid, butyric acid [32], 1,2-propanediol, propionic acid, and n-propanol [33]. Green macroalgae can be processed into hydrolysates containing D-glucose and L-rhamnose; therefore, they have potential applications as an industrial fermentation strain. D-galactosyl-β1→4-rhamnose, which exerts immunomodulatory activity, is produced by a one-pot reaction using a combination of recombinant phosphorylases and dried baker’s yeast [34].

2.3. Bioconversion Using Yeast Cells

As an example of a yeast-based bioconversion application, Greetham et al. investigated the fermentation ability of the marine yeast Wickerhamomyces anomalus M15, particularly for hydrolysis and ethanol production, using brown (Laminaria digitata), green (Ulva linza), and red (Porphyra umbilicalis) macroalgae [35]. After pretreatment with seawater, the highest amount of sugar was liberated by the green macroalga U. linza. In addition, fermentation of Wickerhamomyces anomalus M15 using a concentrated hydrolysate from Ulva linza resulted in the production of 48.2 g/L ethanol, which is equivalent to an overall yield of 0.329 g/g available sugars [35]. As another yeast-based application, Jiang et al. investigated ethanol fermentation using a hydrolysate from the green macroalgae Ulva. They suggested that Saccharomyces cerevisiae RN1016 with xylose isomerase achieved the highest ethanol production levels among the microorganisms examined under the optimized thermochemical conditions [36].

3. Component and Bioconversion of Red Macroalgae

Carrageenan is the main carbohydrate component in red macroalgae such as Eucheuma denticulatum [37], and agar is the main component in species such as Gelidium amansii [38]. During the decomposition of agarose, enzymatic hydrolysis, acid hydrolysis, and acid prehydrolysis with subsequent enzymatic hydrolysis result in the liberation of 3,6-anhydro-α-L-galactose (AHG) and D-galactose for subsequent fermentation [39]. However, the decomposition of carrageenan is difficult because acid treatment produces inhibitory compounds such as acetic acid, furfural, 5-HMF, and levulinic acid [40,41,42]. Therefore, D-galactose and AHG from agarose are suitable target molecules in the use of red macroalgae.
Many marine microorganisms, including Pseudoalteromonas carrageenovora [43], Zobellia galactanivorans [44], Pseudoalteromonas fuliginea [45], and Saccharophagus degradans [46], exhibit agarase activity. Additionally, the catabolic pathway of AHG has been well investigated in the agarolytic marine bacteria Vibrio sp. [47] and Streptomyces sp. [48]. As an example of its application in bioconversion, the AHG catabolic pathway was introduced into an ethanologenic Escherichia coli strain. The engineered strain exhibited 2.0-fold higher AHG consumption and 1.2-fold higher ethanol production compared to the control [49].
As a yeast-based application in bioconversion, a study investigated ethanol production using a hydrolysate derived from the red macroalga Gracilaria verrucosa [50]. Analysis of the relationship between galactose adaptation effects and mRNA transcriptional levels revealed that the use of galactose for ethanol fermentation using Gracilaria verrucosa hydrolysates enhanced the overall ethanol yield in Saccharomyces cerevisiae KCCM 1129 [50]. In another bioconversion method using yeast cells, the representative probiotic yeast S. cerevisiae var. boulardii was used for depolymerization into a beneficial compound, neoagarooligosaccharides, by an endo-type β-agarase [51].

4. Bioactivity of Brown Macroalgae

4.1. Macroalgae Polyphenols or Phlorotannins

Polyphenols are compounds that contain more than two hydroxyl groups. Flavonoids, lignin, and tannins are well-known polyphenols produced by terrestrial organisms [52]. Tannins are further categorized into condensed tannins, which are formed by polymerized flavanols, and hydrolyzable tannins, which are combined with sugar and gallic or ellagic acid via ester bonds [53]. Polyphenols in macroalgae, known as phlorotannins, have a polymerized structure of phloroglucinol and are different from the tannins in terrestrial organisms. Eckols, phlorethols, fucols, fucophlorethols, fuhalols, isofuhalols, and carmalols are the basic structures of phlorotannins bound to phloroglucinol [54,55]. Physiological studies previously carried out on phlorotannins are described below.

4.2. Inhibiting Advanced Glycation End Product (AGE) Formation

AGEs are produced by nonenzymatic reactions between proteins and reducing sugars [56,57]. AGEs play important roles in the development of diabetic complications, osteoporosis, atherosclerosis, sarcopenia, and neuropathy [58,59]. Chemical synthesis has been used to develop glycation inhibitors to suppress AGE production. For example, aminoguanodine [60] and OPB-9195 [61] have been identified as AGE inhibitors; however, they have not been approved for clinical use owing to their adverse effects. Therefore, compounds that are effective against AGE formation have been explored in edible plants [62]. To this end, the antiglycation activities of phlorotannins present in brown macroalgae (Ecklonia cava, Ecklonia kurome, Ecklonia stolonifera, Eisenia arborea, and Eisenia bicyclis) have been studied.

4.3. Effect of Phlorotannins on Methylglyoxal (MGO) Formation

AGEs are produced after the formation of MGO, an α-dicarbonyl compound [63]. Studies have reported that the blood MGO levels were higher in patients with type I diabetes than in healthy people [64,65]. Therefore, phlorotannins extracted from Lessoniaceae were evaluated for their inhibitory activities against fluorescent AGE production in human and bovine serum albumin (HSA and BSA)–MGO models [66]. The inhibitory effect on the formation of fluorescent AGEs was calculated as the half-maximal inhibitory concentration (IC50). Compared with the positive control aminoguanidine hydrochloride (AG) (IC50 = 0.70 mg/mL in the HSA–MGO models and 0.9 mg/mL in the BSA–MGO models), phlorotannins from Lessoniaceae exhibited higher antiglycation activity (Table 1).

4.4. Effect of Phlorotannins on Glyceraldehyde (GA) Formation

GA is also involved in AGE production. AGEs derived from GA form faster than those from MGO [67]. Therefore, many studies have explored inhibitors of the formation of AGEs from GA [68,69,70]. In addition to the serum albumin–MGO models described in the previous section, the inhibitory effects of phlorotannins have been examined using HSA– or BSA–GA models [71]. As a result, phlorotannins from Lessoniaceae exhibited an IC50 of 0.48–0.70 mg/mL (Table 2). The inhibitory effect of phlorotannins derived from Eisenia bicyclis on fluorescent AGEs was 2.3–3.7-fold higher than that of AG as a positive control.

4.5. Effect of Phlorotannins on Nε-(Carboxymethyl)lysine (CML)

CML is an AGE formed by the oxidation of glucose with lysine [72]. In human dermal fibroblasts, CML–collagen decreased the ability of epidermal keratinocytes to adhere to collagen and induce apoptosis [73]. CML–collagen inhibits collagen cross-linking in osteoblasts and causes diabetic osteopenia [74,75]. The suppression of CML formation in these diseases is thought to be clinically important. Recently, the inhibitory effect of phlorotannins on CML formation was examined [76]. The inhibitory effect following treatment with phlorotannins from Lessoniaceae on CML formation was 0.16 μg/mL, which was distinctively lower than that following treatment with 0.40 mM AG as a positive control. Phloroglucinol and eckols inhibit CML formation at concentrations approximately 317–1818-fold lower than those of AG [76]. Taken together, phlorotannins can be considered potential inhibitors of CML formation.

5. Microbial Conversion of Macroalgae

5.1. Microorganisms and Their Enzymes

To develop bioconversion methods for algae, an effective method for crushing and saccharifying seaweed bodies is crucial. Considering these situations, algae-degrading microorganisms can be exploited to develop a sustainable tool for algal processing. Previous outbreaks of seaweed diseases have led to the screening of algae-degrading bacteria. The marine bacterium Alteromonas elyakovii KMM 162T was isolated from spot-wounded fronds of the brown macroalga Laminaria japonica [77]. Similar to other brown algae, Fucus evanescens-degrading bacteria, Pseudoalteromonas sp., and Halomonas sp. have also been isolated previously [78].
Tanaka et al. isolated four brown algae-degrading Gram-negative bacteria, namely Formosa haliotis strains from the gut of the abalone Haliotis gigantea [79]. Furthermore, they performed genomic analysis of the Formosa haliotis strain MA1 (LMG 28520T) to reveal the mechanism of degradation of seaweed bodies. As a result, more genes related to macromolecule degradation were identified compared with conventional marine bacteria [79]. Several genes related to hydrocarbon degradation and gene clusters related to alginate degradation have been identified.
Furthermore, genes encoding alginate lyase family PL-7, an oligoalginate lyase classified as alginate lyase (family PL-17), 4-deoxy-l-erythro-5-hexoseulose uronic acid (DEH) reductase, KdgF, 2-keto-3-deoxy-D-gluconate (KDG) kinase, and 2-dehydro-3-deoxy-phosphogluconate aldolase have been identified [80]. The KDG produced by this cluster is further metabolized in a major biochemical pathway of sugars. Using this gene cluster, Formosa haliotis may effectively and functionally use fewer compounds in marine environments than in terrestrial environments [80].

5.2. Degradation of Alginate

Alginate-degrading bacteria are considered industrially important because products using alginate lyases can be applied in the pharmaceutical industry, the food industry, and bioethanol production [81]. Several researchers have investigated alginolytic strains in the environment and identified them as Sphingomonas sp. strain A1 [82], Zobellia galactanivorans [83], Vibrio splendidus strain 12B01 [84], and Saccharophagus degradans strain 2–40 [85]. Alginate-degrading bacteria have been further explored for the efficient production of rare sugars from brown macroalgae by screening algae-corrupting bacteria. As a result of this screening, Falsirhodobacter sp. strain alg1 was isolated and analyzed [81,86]. Although there are only two alginate lyases, namely, AlyFRA and AlyFRB, in strain alg1, DEH was effectively produced by controlling the ratio of the two enzymes [81].

5.3. Immobilization of Recombinant Alginate Lyase

To achieve effective and sustainable DEH production, microbial strains of Escherichia coli, Saccharomyces cerevisiae, and Sphingomonas sp. A1 were developed by introducing genes encoding alginate lyase and other enzymes related to DEH fermentation and bioethanol production [87,88]. These strains can produce ethanol directly from sodium alginate. The enzymatic reactions of recombinant endo-alginate lyase Alg7D and exo-alginate lyase Alg17C from Saccharophagus degradans yielded 45.5% DEH (DEH weight/alginate weight) from alginate [89].
Considering the industrial applications of DEH, increasing the yield of DEH and examining the reusability of enzymes are warranted to minimize costs. In general, enzyme reusability can be attained by immobilizing the enzymes into carrier materials. Moreover, the immobilized enzymes can be handled as solids and readily separated from the reaction mixture containing the products. Tanaka et al. examined DEH production using free and immobilized alginate lyases, endo-type AlyFRA, and exo-type AlyFRB from Falsirhodobacter sp. alg1 [90].
The investigation using LC-MS revealed that the reaction of both recombinant enzymes rAlyFRA and rAlyFRB with sodium alginate generated highly purified DEH. Next, AlyFRA- and AlyFRB-immobilized enzymes with κ-carrageenan were prepared as iAlyFRA and iAlyFRB, respectively. The immobilization rates of AlyFRA and AlyFRB increased as the concentration of κ-carrageenan increased, and their κ-carrageenan gels were less fragile. Immobilized enzymes prepared with 4.0% (w/v) κ-carrageenan completely degraded the substrate and produced DEH in the seventh batch reaction [90]. Considering these facts, the immobilization of AlyFRA and AlyFRB can effectively and economically produce large amounts of DEH from sodium alginate. Therefore, the industrial-scale production of DEH via the extraction of saccharified liquid containing alginate from brown algae can be developed by improving the immobilization conditions and carrier materials.

6. Molecular Display Technology for Macroalgae Utilization

6.1. Technology for Immobilizing Proteins on the Cell Surface

After the development of genetic engineering, molecular display technology or cell surface engineering was developed for various biological investigations and was conveniently applied to prepare recombinant proteins in bioprocesses [91,92,93]. The first technology in this field was the so-called “phage display” technology, which was developed by Smith [94]. In this technology, a foreign protein is inserted into the filamentous phage protein III via genetic manipulation, and its fusion protein is produced on the virion surface. This technology is currently used for screening combinatorial proteins or clones of peptide ligands [95,96]; however, it is difficult to perform and involves steps such as infection of Escherichia coli cells with phages for the recovery of positive clones. This technical challenge can be solved using molecular display technology with bacterial cells, which can provide an easier display system without infection and can display large numbers of proteins [97,98].
Since the development of E. coli as a host bacterium for molecular display technology [99,100], several bacteria, such as Acetivibrio cellulolyticus [101], Bacillus subtilis [102], Lactobacillus [103], and Staphylococcus [104], have been effectively used for biotechnological applications. Depending on the biochemical or physical characteristics of foreign proteins, manifold bacterial hosts have been developed for surface display. However, it is difficult to achieve high-throughput screening of positive clones from libraries using a flow cytometer or microscope and to determine the levels of eukaryotic proteins using bacterial surface display technology.

6.2. Yeast Display System

The yeast Saccharomyces cerevisiae is well known as a useful host of genetic biotechnology because it can fold and glycosylate heterologous eukaryotic proteins. Furthermore, these cells are economically advantageous for high-density cultivation. Moreover, yeast cells can be used to express different proteins using several genetic markers. Indeed, various studies have reported that yeast can display different kinds of protein, the so-called “co-display” [105,106,107]. This molecular display system enabled us to perform high-throughput screening using conventional devices such as a flow cytometer or a multiwell plate reader [108,109].
The cell surface of the yeast Saccharomyces cerevisiae comprises β-glucans and mannoproteins [110], which exist outside the cell membrane. Cell wall proteins, such as agglutinins (Aga1 and Aga2), Flo1, Sed1, and Cwp1, are well-known anchor molecules that can retain target proteins on the yeast cell surface. In addition to these proteins, α-agglutinin is also one of the most widely used anchoring proteins for heterologous proteins in the yeast display system. A target and α-agglutinin fusion protein is produced by introducing multicopy plasmids or integrative plasmids into the host strain. A fusion protein in the system is transiently transported to the exterior of the cell membrane by secretory vesicles and then released by an enzymatic reaction involving phosphatidylinositol-specific phospholipase C. Finally, the target–α-agglutinin fusion protein is transferred to the cell wall [111,112]. Using the Saccharomyces cerevisiae–α-agglutinin display system, enzymes, fluorescent proteins [108], antibodies, and peptides [91] have been successfully displayed on the cell surface and used as elements of biomonitoring [113], adsorbents for screening of protein libraries [114], oral vaccines [115,116], catalysts in bioconversion, etc. Enzymes displayed on yeast cells can be repeatedly used via centrifugation with a synergistic conversion associated with the yeast intracellular metabolic pathway. Cells with the ability to degrade macroalgae and ferment macroalgal components have been developed by using molecular display technology, as described below.

6.3. Bioethanol Production from Laminarin

As described earlier, brown algae have the potential to be used to produce biomass energy because they do not compete with food and do not contain persistent lignin. As mentioned in the Introduction, brown algae contain up to 35% lignin on a dry weight basis [16] and have attracted much attention in the field of energy production. Nevertheless, they have not yet been effectively used as biomass because they cannot decompose into glucose. Therefore, to use brown algae, it is necessary to degrade laminarin to produce glucose for assimilation during alcohol fermentation.
Laminarinase, i.e., β-1,3-glucanase and β-1,6-glucanase, can produce glucose from polysaccharides for ethanol production [117]. Studies have reported ethanol production from laminarin using microorganisms [118,119,120]. Pichia angophorae can directly produce ethanol from laminarin [120]; however, it does not exhibit salt tolerance, unlike Saccharomyces cerevisiae [121]. In bioethanol production from brown macroalgae, the salt-tolerant characteristics of microbial cells would be advantageous. Saccharomyces cerevisiae has been used in the fermentation industry and can produce high levels of ethanol; however, it cannot assimilate laminarin.
Using qualitative proteomic analysis, Motone et al. reported that the marine, laminarin-assimilating bacterium Saccharophagus degradans strain 2–40 exhibits a high ability to degrade polysaccharides for bioethanol production [122]. In the multicomponent enzyme system of S. degradans 2–40, various polysaccharides, including agar, alginate, cellulose, hemicellulose, and laminarin, can be degraded [123]. In a proteomic study, 92 molecules, including 6 carbohydrases, were identified as proteins specifically produced during cultivation in a laminarin-containing medium [122]. Among the identified carbohydrases, Gly16G, Lam16B, and Gly5M belong to the glycoside hydrolase family 5 or 16 [122].
Although Gly16G and Lam16B have already been predicted to be laminarinases [123], the catalytic machinery of Gly16G is missing according to NCBI (http://www.ncbi.nlm.nih.gov/ accessed on 1 March 2023). Moreover, the molecular weight of Lam16B is extremely high and is therefore thought to be unsuitable for cell surface displays [124,125]. As a result, Gly5M was selected as the candidate hydrolytic enzyme for laminarin and displayed on the yeast cell surface. In the reaction between laminarin and Gly5M-displying yeast, oligosaccharides were produced, and Gly5M was suggested to be a novel hydrolytic enzyme for laminarin. Analysis of the produced oligosaccharides revealed that most comprised gentiobiose, with two glucose molecules linked by a β-1,6-glycosidic bond. Furthermore, Aspergillus aculaeatus β-glucosidase (BG)-displaying yeast was used to achieve ethanol production from laminarin. Cocultivation of Gly5M- and BG-displaying yeast strains was performed in a medium containing 20 g/L laminarin as the sole carbon source. As a result, 5.2 g/L of ethanol (corresponding to 46% of the theoretical yield) was produced under optimized conditions [122]. A study revealed that ethanol productivity depends on the initial inoculation ratio of the two yeast strains, and the proportion of the two enzymes is important in fermentation [122]. This cocultivation system using Gly5M- and BG-displaying yeast strains could be a powerful tool for ethanol production using laminarin in brown macroalgae.

6.4. Bioethanol Production from Xylan

Xylan is present in macroalgae and comprises a heteropolysaccharide with β-1,4-linked xylopyranoside. It constitutes >90% of the hemicellulose content [126]. Bioconversion of xylan into bioethanol can be an efficient and sustainable method for bioethanol production from nonedible biomass derived from macroalgae. In a previous study, xylan-degrading xylanase II (XYNII) from Trichoderma reesei and beta-xylosidase (XylA) from Aspergillus oryzae were codisplayed [127]. The XYNII- and XylA-displaying strain was used for direct ethanol production from birchwood xylan. The strain could produce D-xylose using the displayed enzymes, and fermentation of D-xylose was achieved by introducing the oxidoreductase-based enzymes NAD(P)H-dependent D-xylose reductase and xylitol dehydrogenase [128]. However, these enzymes cause intracellular redox imbalance and accumulation of by-products. An increase in cytosolic xylitol and glycerol leads to a decrease in the yield of ethanol [129,130].
Another route for the production of xylose involving isomerase (XI), which is predominantly derived from bacteria and catalyzes the isomerization of D-xylose into D-xylulose, has been investigated [131]. XI does not require coenzymes for isomerization. Moreover, using XI, higher theoretical yields (0.51 g ethanol/g xylose) can be achieved compared with the conventional pathway (0.46 g ethanol/g xylose) [132]. Ota et al. developed Saccharomyces cerevisiae displaying xylose isomerase (XylC) from Clostridium cellulovorans that can simultaneously isomerize and ferment D-xylose [133]. D-xylose isomerization in the cultivation medium has the potential to utilize D-xylose because D-xylulose is promptly absorbed by yeast cells via different uptake routes, unlike D-xylose uptake [134,135]. Nevertheless, ethanol production was low in this study [133] because of the limited catalytic activity of XylC.
To enhance the catalytic activity of enzymes, it is important to optimize the concentration of specific cofactors because metal cations such as Co2+, Mg2+, or Mn2+ increase the activity and stability of XIs [136]. To improve the cell surface enzymatic activity of XylC-displaying yeast, specific metal cations have also been studied [137]. In this study, XylC-displaying yeast cells were cultivated and incubated in buffered solutions containing D-xylose and the following metal ions: Mn2+, Fe2+, Fe3+, Co2+, Co3+, Ni2+, Cu2+, and Mg2+. Co2+ markedly improved the catalytic activity of XylC on the yeast cell surface by 46-fold. As a result, Co2+ supplementation was introduced in the coculture system using two yeast strains, i.e., xylan-degrading Saccharomyces cerevisiae strain, which codisplays an endo-1,4-β-xylanase from Saccharophagus degradans 2–40 [138] and a β-xylosidase from Aspergillus niger [139], and a Saccharomyces cerevisiae strain that displays XylC (Figure 2). Supplementation of 3 mM Co2+ was the most effective cofactor for ethanol fermentation. In addition, the ethanol production rate and consumption rate of D-xylose were 38 ± 7.1 mg ethanol·g-cell−1·h−1 and 150 ± 3.6 mg xylose·g-cell−1·h−1, respectively. They were prominently improved compared with fermentation without Co2+ supplementation (6.3 ± 0.79 mg ethanol xylose·g-cell−1·h−1 and 56 ± 2.7 mg xylose·g-cell−1·h−1, 6.0- and 2.7-fold, respectively) [137].
Various enzymes from different microbial species may be an effective solution for fermenting xylan derived from macroalgae into ethanol. For example, the degradation of macroalgal xylan by xylanases from microbes such as Cryptococcus and Thermomyces has been investigated [140].

6.5. Bioethanol Production from Alginate and Mannitol

Introduction of the DEH transporter and components of the DEH metabolic pathway (DehR, KdgK, and KdgpA) into Saccharomyces cerevisiae is required for DEH assimilation because Saccharomyces cerevisiae cannot assimilate DEH. Enquist-Newmam et al. constructed a Saccharomyces cerevisiae strain that can use both DEH and mannitol [141]. To screen for a DEH transporter, the Saccharomyces cerevisiae strain BAL2193 was constructed by genomically integrating genes for DEH assimilation (dehR from Sphingomonas sp. strain A1, kdgK from Saccharophagus degradans, and kdgpA from Vibrio splendidus). Codon-optimized dehR from Vibrio harveyi, kdgK from Escherichia coli, and kdgpA from Vibrio splendidus were selected for engineering Saccharomyces cerevisiae using an enzymatic assay of the cell lysate and ethanol productivity. The resulting strain produced 36 g/L ethanol from a 98 g/L sugar mixture (alginate and mannitol). The metabolically modified Saccharomyces cerevisiae could generate ethanol from DEH and mannitol; however, unmodified Saccharomyces cerevisiae lacked the ability to utilize alginate [141].
Takagi et al., focused on secreted alginate lyases (Alg7D and Alg18J) and lipobox-containing cell-surface-attached alginate lyases (Alg7A and Alg7K) in Saccharophagus degradans and displayed them on Saccharomyces cerevisiae W303-1A [142]. Alg7A-, Alg7D-, and Alg18J-displaying strains exhibited endolytic alginate lyase activity, whereas the Alg7K-displaying strain exhibited exolytic alginate lyase activity. In addition to investigating the substrate specificity of the displayed alginate lyases, they produced yeasts codisplaying endolytic and exolytic alginate lyases. The degradation efficiency of these codisplaying strains was significantly higher than that of single alginate lyase-displaying strains. The Alg7A- and Alg7K-codisplaying strain had the highest alginate-degrading activity, producing 1.98 g/L reducing sugars [142].
Yeast molecular display technology has been further improved for direct ethanol production from alginate and mannitol in brown macroalgae (Figure 3) [143]. First, the genes encoding the components of the DEH pathway that produce ethanol directly from alginate and mannitol were examined. Then, the genes encoding Alg7A and Alg7K from Saccharophagus degradans, DHT1 from Asteromyces cruciatus, dehR from Vibrio splendidus, and kdgK from Escherichia coli were examined. Furthermore, mannitol-metabolizing capacity was enhanced to control the redox balance during prolonged cultivation using a medium with mannitol as the sole carbon source. The resulting strain, alginate- and mannitol-assimilating (AM1), was cultivated in a medium containing 6% (w/v) of total sugar (approximately 1:2 ratio of alginate/mannitol). The strain could directly produce ethanol from alginate and mannitol and obtained 8.8 g/L of ethanol (Figure 4), with yields of up to 32% of the theoretical yield [143].
Alginate is initially degraded into oligosaccharides by Alg7A. These oligosaccharides are then sequentially degraded into monosaccharides by Alg7K. DEH is transported into the cytoplasmic space by the DEH transporter. Mannitol is converted to D-fructose by mannitol-2-dehydrogenase. This figure has been adapted from a previous study [143].
As another platform for bioethanol production using macroalgae, a cocultivation system using two different Saccharomyces cerevisiae strains, i.e., the cellulase-displaying strain (CDY) and AM1 strain, has recently been developed. The yeast CDY strain for ethanol production from glucan codisplays the cellulases endoglucanase, cellobiohydrolase, and BG on its cell surface [144].
Sasaki et al., developed a system using the Saccharomyces cerevisiae strains CDY and AM1 [145]. In the study, the acid hydrolysate of the brown macroalga Ecklonia kurome was used as the carbon source in the fermentation medium. The inoculation rate of cocultivated yeast is important for simultaneous utilization because there are varying amounts of carbohydrate components in brown algae. The cocultivation rate of the AM1 and CDY strains (4:1) was 2.10 ± 0.70 g/L of ethanol production. This yield was slightly higher than that produced by a monoculture of the AM1 strain and 2.1-fold higher than that produced by a monoculture of the CDY strain. In addition, peaks in mannitol, laminarin, and alginate stores in brown macroalgae appear around July, September, and from January to March, respectively [146,147]. Therefore, the harvesting season is also an important factor that should be examined to improve the production efficiency of ethanol and genetic and metabolic engineering.

6.6. Recovery of Metal Ions

For a long time, various types of bacteria have been examined in studies on the recovery of metal ions from aquatic environments [148,149,150,151]. Recently, algae have been shown to exhibit absorption abilities [151]. At present, macroalgae have better performance ability than microalgae, followed by cyanobacteria. For example, a study suggested that brown macroalgae have the most potential as bioadsorbents, with Undaria pinnatifida having an absorption ability of 0.6 mmol g−1 of total metals [152]. Another brown macroalga, Fucus vesiculosus, exhibited high absorption ability for Hg, Pb, and Cd [153]. Biopolymers derived from the alginate of Ecklonia sp. were suggested to be chelating materials for Pb2+, Cu2+, Cd2+, As3+, and Ag+, which are considered environmental pollutants [154]. Absorption using macroalgae for toxic metals and rare earth elements such as La, Ce, Pr, Nd, Eu, Gd, Tb, and Y, has also been investigated [155,156,157,158].
In a previous study on molecular display technology, metal-binding properties were endowed on yeast cell surfaces, and the engineered yeast cells were regarded as bioadsorbents [159,160]. These bioadorbents were used to recover metal ions from the extracts of macroalgae that absorb and enrich metal ions in the sea. The construction of yeast cells with the ability to absorb heavy metal ions, metal-binding proteins, and peptides has been demonstrated on the Saccharomyces cerevisiae cell surface. First, a hexa-histidine peptide (hexa-His) [161] and the metal-binding protein yeast metallothionein (YMT) [162] were displayed. The ability of the hexa-his- or YMT-displaying yeast strains to absorb Cu2+, Ni2+, or Cd2+ was distinctively observed and enhanced compared with those of the control host strain. In addition, these yeast strains grew even in media containing Cu2+ or Cd2+ at toxic concentrations [161,162]. The separation process of cell-surface-bound heavy metal ions from the yeast cell surface was also developed for practical application in the bioremediation of contaminated hydrospheres. Furthermore, to enhance the utility of hexa-his- or YMT-displaying yeast strains for the recovery of metal ions, a system of self-aggregation of cells that bind to metal ions was introduced [163]. Because the Gts1 protein can induce strong aggregation when overexpressed, GTS1 was expressed under the control of the CUP1 promoter, which functions by increasing Cu2+ in the cells. Gts1-controlling aggregation of the resulting yeast strain was successfully achieved in response to Cu2+ in the medium. As another improvement in the metal-binding ability of Saccharomyces cerevisiae, multiple YMTs were displayed tandemly; this strain had an enhanced ability to recover metal ions depending on the frequency of tandem repeats [164]. The metal-binding ability of Saccharomyces cerevisiae endowed by molecular display systems has been applied not only to heavy metal ions but also to rare metal ions. For example, the ModE protein derived from Escherichia coli was displayed on the yeast, and its molybdate-binding ability was observed [165]. In addition, uranyl ions were recovered using yeast strains displaying NikR mutant proteins from Escherichia coli [166]. Further development of these metal-binding yeast strains could help in the recovery of various metal ions from extracts of macroalgae and other types of macroalgae.

7. Summary

We provided an overview of the bioconversion of macroalgae, mainly brown macroalgae, using microbial biotechnology. Terrestrial natural resources have met the expectations for food supply, energy, or valuable substances worldwide. To achieve sustainable development, biotechnological processes in particular have been developed and introduced into various processes, including the manufacturing and energy industries. To promote sustainability in these processes, it is not only important to use highly sophisticated technology but also to select natural resources. Therefore, the use of macroalgae instead of conventional terrestrial resources is considered suitable for these situations. Nevertheless, further screening of microorganisms from different regions is warranted to convert macroalgae into desirable feedstocks. In the future, genetic engineering, such as molecular display technology, will continue to provide ecofriendly tools for energy production and will be widely developed for the use of macroalgae.
Macroalgae contain several compounds for which there is high demand. A solution or technology that can be employed to preserve their habitat and marine resources should be discovered or developed to continue the harmonious use of macroalgae with the circle of life [167].

Author Contributions

Writing—original draft preparation, S.S.; writing—review and editing, M.U. All authors have read and agreed to the published version of the manuscript.

Funding

This review article received no external funding.

Data Availability Statement

Not applicable.

Acknowledgments

The research in this article was partially supported by the project JPNP18016 commissioned by the New Energy and Industrial Technology Development Organization (NEDO).

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Ali, M.; Seraj, M. Nexus between energy consumption and carbon dioxide emission: Evidence from 10 highest fossil fuel and 10 highest renewable energy-using economies. Environ. Sci. Pollut. Res. Int. 2022, 29, 87901–87922. [Google Scholar] [CrossRef] [PubMed]
  2. Coskun, D.; Britto, D.T.; Kronzucker, H.J. Nutrient constraints on terrestrial carbon fixation: The role of nitrogen. J. Plant Physiol. 2016, 203, 95–109. [Google Scholar] [CrossRef] [PubMed]
  3. Gray, K.A.; Zhao, L.; Emptage, M. Bioethanol. Curr. Opin. Chem. Biol. 2006, 10, 141–146. [Google Scholar] [CrossRef] [PubMed]
  4. Macrelli, S.; Mogensen, J.; Zacchi, G. Techno-economic evaluation of 2nd generation bioethanol production from sugar cane bagasse and leaves integrated with the sugar-based ethanol process. Biotechnol. Biofuels 2012, 5, 22. [Google Scholar] [CrossRef] [Green Version]
  5. Pavlečić, M.; Rezić, T.; Šantek, M.I.; Horvat, P.; Šantek, B. Bioethanol production from raw sugar beet cossettes in horizontal rotating tubular bioreactor. Bioprocess Biosyst. Eng. 2017, 40, 1679–1688. [Google Scholar] [CrossRef]
  6. Rizzolo, J.A.; Woiciechowski, A.L.; Júnior, A.I.M.; Torres, L.A.Z.; Soccol, C.R. The potential of sweet potato biorefinery and development of alternative uses. SN Appl. Sci. 2021, 3, 347. [Google Scholar] [CrossRef]
  7. Hoppert, L.; Kölling, R.; Einfalt, D. Investigation of stress tolerance of Pichia kudriavzevii for high gravity bioethanol production from steam-exploded wheat straw hydrolysate. Bioresour. Technol. 2022, 364, 128079. [Google Scholar] [CrossRef] [PubMed]
  8. Silva, S.R.B.; de Lima Neto, J.X.; Fuzo, C.A.; Fulco, U.L.; Vieira, D.S. A quantum biochemistry investigation of the protein-protein interactions for the description of allosteric modulation on biomass-degrading chimera. Phys. Chem. Chem. Phys. 2020, 22, 25936–25948. [Google Scholar] [CrossRef]
  9. Ross, A.B.; Jones, J.M.; Kubacki, M.L.; Bridgeman, T. Classification of macroalgae as fuel and its thermochemical behaviour. Bioresour. Technol. 2008, 99, 6494–6504. [Google Scholar] [CrossRef]
  10. Gordillo Sierra, A.R.; Amador-Castro, L.F.; Ramírez-Partida, A.E.; García-Cayuela, T.; Carrillo-Nieves, D.; Alper, H.S. Valorization of Caribbean Sargassum biomass as a source of alginate and sugars for de novo biodiesel production. J. Environ. Manag. 2022, 324, 116364. [Google Scholar] [CrossRef]
  11. FitzGerald, J.A.; Allen, E.; Wall, D.M.; Jackson, S.A.; Murphy, J.D.; Dobson, A.D. Methanosarcina Play an Important Role in Anaerobic Co-Digestion of the Seaweed Ulva lactuca: Taxonomy and Predicted Metabolism of Functional Microbial Communities. PLoS ONE 2015, 10, e0142603. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  12. Roy, A.; Gogoi, N.; Yasmin, F.; Farooq, M. The use of algae for environmental sustainability: Trends and future prospects. Environ. Sci. Pollut. Res. Int. 2022, 29, 40373–40383. [Google Scholar] [CrossRef] [PubMed]
  13. Demirbas, A. Use of algae as biofuel sources. Energy Convers. Manag. 2010, 51, 2738–2749. [Google Scholar] [CrossRef]
  14. Corino, C.; Modina, S.C.; Di Giancamillov, A.; Chiapparini, S.; Rossi, R. Seaweeds in Pig Nutrition. Animals 2019, 9, 1126. [Google Scholar] [CrossRef] [Green Version]
  15. Rioux, L.E.; Turgeon, S.L.; Beaulieu, M. Structural characterization of laminaran and galactofucan extracted from the brown seaweed Saccharina longicruris. Phytochemistry 2010, 71, 1586–1595. [Google Scholar] [CrossRef]
  16. Kadam, S.U.; Tiwari, B.K.; O’Donnell, C.P. Extraction, structure and biofunctional activities of laminarin from brown algae. Int. J. Food Sci. Tech. 2015, 50, 24–31. [Google Scholar] [CrossRef]
  17. Reed, R.H.; Davison, J.A.; Chudek, J.A.; Foster, R. The osmotic role of mannitol in the Phaeophyta: An appraisal. Phycologia 1985, 24, 35–47. [Google Scholar] [CrossRef]
  18. Harnedy, P.A.; FitzGerald, R.J. Bioactive proteins peptides and amino acids from macroalgae(1). J. Phycol. 2011, 47, 218–232. [Google Scholar] [CrossRef]
  19. Hentati, F.; Tounsi, L.; Djomdi, D.; Pierre, G.; Delattre, C.; Ursu, A.V.; Fendri, I.; Abdelkafi, S.; Michaud, P. Bioactive Polysaccharides from Seaweeds. Molecules 2020, 25, 3152. [Google Scholar] [CrossRef]
  20. Cotas, J.; Leandro, A.; Monteiro, P.; Pacheco, D.; Figueirinha, A.; Gonçalves, A.M.M.; da Silva, G.J.; Pereira, L. Seaweed Phenolics: From Extraction to Applications. Mar. Drugs 2020, 18, 384. [Google Scholar] [CrossRef]
  21. Robic, A.; Bertrand, D.; Sassi, J.F.; Lerat, Y.; Lahaye, M. Determination of the chemical composition of ulvan, a cell wall polysaccharide from Ulva spp. (Ulvales, Chlorophyta) by FT-IR and chemometrics. J. Appl. Phycol. 2009, 21, 451–456. [Google Scholar] [CrossRef]
  22. Dutschei, T.; Zühlke, M.K.; Welsch, N.; Eisenack, T.; Hilkmann, M.; Krull, J.; Stühle, C.; Brott, S.; Dürwald, A.; Reisky, L.; et al. Metabolic engineering enables Bacillus licheniformis to grow on the marine polysaccharide ulvan. Microb. Cell Fact. 2022, 21, 207. [Google Scholar] [CrossRef] [PubMed]
  23. Collén, P.N.; Jeudy, A.; Sassi, J.F.; Groisillier, A.; Czjzek, M.; Coutinho, P.M.; Helbert, W. A novel unsaturated β-glucuronyl hydrolase involved in ulvan degradation unveils the versatility of stereochemistry requirements in family GH105. J. Biol. Chem. 2014, 289, 6199–6211. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  24. Konasani, V.R.; Jin, C.; Karlsson, N.G.; Albers, E. A novel ulvan lyase family with broad-spectrum activity from the ulvan utilisation loci of Formosa agariphila KMM 3901. Sci. Rep. 2018, 8, 14713. [Google Scholar] [CrossRef] [Green Version]
  25. Koller, F.; Lassak, J. Two RmlC homologs catalyze dTDP-4-keto-6-deoxy-D-glucose epimerization in Pseudomonas putida KT2440. Sci. Rep. 2021, 11, 11991. [Google Scholar] [CrossRef]
  26. van der Wal, H.; Sperber, B.; Houweling-Tan, B.; Bakker, R.; Brandenburg, W.; López-Contreras, A.M. Production of acetone butanol and ethanol from biomass of the green seaweed Ulva lactuca. Bioresour. Technol. 2013, 128, 431–437. [Google Scholar] [CrossRef]
  27. Song, Y.; He, P.; Rodrigues, A.L.; Datta, P.; Tandon, R.; Bates, J.T.; Bierdeman, M.A.; Chen, C.; Dordick, J.; Zhang, F.; et al. Anti-SARS-CoV-2 Activity of Rhamnan Sulfate from Monostroma nitidum. Mar. Drugs 2021, 19, 685. [Google Scholar] [CrossRef]
  28. Cassolato, J.E.; Noseda, M.D.; Pujol, C.A.; Pellizzari, F.M.; Damonte, E.B.; Duarte, M.E. Chemical structure and antiviral activity of the sulfated heterorhamnan isolated from the green seaweed Gayralia oxysperma. Carbohydr. Res. 2008, 343, 3085–3095. [Google Scholar] [CrossRef]
  29. Surayot, U.; Wang, J.; Lee, J.H.; Kanongnuch, C.; Peerapornpisal, Y.; You, S. Characterization and immunomodulatory activities of polysaccharides from Spirogyra neglecta (Hassall) Kützing. Biosci. Biotechnol. Biochem. 2015, 79, 1644–1653. [Google Scholar] [CrossRef]
  30. Wassie, T.; Niu, K.; Xie, C.; Wang, H.; Xin, W. Extraction Techniques Biological Activities and Health Benefits of Marine Algae Enteromorpha prolifera Polysaccharide. Front. Nutr. 2021, 8, 747928. [Google Scholar] [CrossRef]
  31. Ropellato, J.; Carvalho, M.M.; Ferreira, L.G.; Noseda, M.D.; Zuconelli, C.R.; Gonçalves, A.G.; Ducatti, D.R.B.; Kenski, J.C.N.; Nasato, P.L.; Winnischofer, S.M.B.; et al. Sulfated heterorhamnans from the green seaweed Gayralia oxysperma: Partial depolymerization chemical structure and antitumor activity. Carbohydr. Polym. 2015, 117, 476–485. [Google Scholar] [CrossRef] [PubMed]
  32. Patakova, P.; Branskav, B.; Vasylkivska, M.; Jureckova, K.; Musilova, J.; Provaznik, I.; Sedlar, K. Transcriptomic studies of solventogenic clostridia Clostridium acetobutylicum and Clostridium beijerinckii. Biotechnol. Adv. 2022, 58, 107889. [Google Scholar] [CrossRef] [PubMed]
  33. Diallo, M.; Simons, A.D.; van der Wal, H.; Collas, F.; Houweling-Tan, B.; Kengen, S.W.M.; López-Contreras, A.M. l-Rhamnose Metabolism in Clostridium beijerinckii Strain DSM 6423. Appl. Environ. Microbiol. 2019, 85, e02656-18. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  34. Nakajima, M.; Nishimoto, M.; Kitaoka, M. Practical preparation of D-galactosyl-beta1-->4-L-rhamnose employing the combined action of phosphorylases. Biosci. Biotechnol. Biochem. 2010, 74, 1652–1655. [Google Scholar] [CrossRef] [Green Version]
  35. Greetham, D.; Adams, J.M.; Du, C. The utilization of seawater for the hydrolysis of macroalgae and subsequent bioethanol fermentation. Sci. Rep. 2020, 10, 9728. [Google Scholar] [CrossRef]
  36. Jiang, R.; Linzon, Y.; Vitkin, E.; Yakhini, Z.; Chudnovsky, A.; Golberg, A. Thermochemical hydrolysis of macroalgae Ulva for biorefinery: Taguchi robust design method. Sci. Rep. 2016, 6, 27761. [Google Scholar] [CrossRef] [Green Version]
  37. Gregersen, S.; Kongsted, A.H.; Nielsen, R.B.; Hansen, S.S.; Lau, F.A.; Rasmussen, J.B.; Holdt, S.L.; Jacobsen, C. Enzymatic extraction improves intracellular protein recovery from the industrial carrageenan seaweed Eucheuma denticulatum revealed by quantitative subcellular protein profiling: A high potential source of functional food ingredients. Food Chem. X 2021, 12, 100137. [Google Scholar] [CrossRef]
  38. Park, J.H.; Hong, J.Y.; Jang, H.C.; Oh, S.G.; Kim, S.H.; Yoon, J.J.; Kim, Y.J. Use of Gelidium amansii as a promising resource for bioethanol: A practical approach for continuous dilute-acid hydrolysis and fermentation. Bioresour. Technol. 2012, 108, 83–88. [Google Scholar] [CrossRef]
  39. Yu, S.; Yun, E.J.; Kim, D.H.; Park, S.Y.; Kim, K.H. Anticariogenic Activity of Agarobiose and Agarooligosaccharides Derived from Red Macroalgae. J. Agric. Food Chem. 2019, 67, 7297–7303. [Google Scholar] [CrossRef]
  40. Zheng, M.; Zheng, Y.; Zhang, Y.; Zhu, Y.; Yang, Y.; Oda, T.; Ni, H.; Jiang, Z. In vitro fermentation of Bangia fuscopurpurea polysaccharide by human gut microbiota and the protective effects of the resultant products on Caco-2 cells from lipopolysaccharide-induced injury. Int. J. Biol. Macromol. 2022, 222 Pt A, 818–829. [Google Scholar] [CrossRef]
  41. Cheong, K.L.; Qiu, H.M.; Du, H.; Liu, Y.; Khan, B.M. Oligosaccharides Derived from Red Seaweed: Production Properties and Potential Health and Cosmetic Applications. Molecules 2018, 23, 2451. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  42. Kholiya, F.; Rathod, M.R.; Gangapur, D.R.; Adimurthy, S.; Meena, R. An integrated effluent free process for the production of 5-hydroxymethyl furfural (HMF) levulinic acid (LA) and KNS-ML from aqueous seaweed extract. Carbohydr. Res. 2020, 490, 107953. [Google Scholar] [CrossRef] [PubMed]
  43. Barbeyron, T.; Henrissat, B.; Kloareg, B. The gene encoding the kappa- carrageenase of Alteromonas carrageenovora is related to β-1,3-1,4-glucanases. Gene 1994, 139, 105–109. [Google Scholar] [CrossRef] [PubMed]
  44. Jam, M.; Flament, D.; Allouch, J.; Potin, P.; Thion, L.; Kloareg, B.; Czjzek, M.; Helbert, W.; Michel, G.; Barbeyron, T. The endo-β-agarases AgaA and AgaB from the marine bacterium Zobellia galactanivorans: Two paralogue enzymes with different molecular organizations and catalytic behaviours. Biochem. J. 2005, 385, 703–713. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  45. Pluvinage, B.; Robb, C.S.; Jeffries, R.; Boraston, A.B. The structure of PfGH50B an agarase from the marine bacterium Pseudoalteromonas fuliginea PS47. Acta Crystallogr. F Struct. Biol. Commun. 2020, 76, 422–427. [Google Scholar] [CrossRef] [PubMed]
  46. Pluvinage, B.; Hehemann, J.H.; Boraston, A.B. Substrate recognition and hydrolysis by a family 50 exo-β-agarase Aga50D from the marine bacterium Saccharophagus degradans. J. Biol. Chem. 2013, 288, 28078–28088. [Google Scholar] [CrossRef] [Green Version]
  47. Yu, S.; Yun, E.J.; Kim, D.H.; Park, S.Y.; Kim, K.H. Dual Agarolytic Pathways in a Marine Bacterium Vibrio sp. Strain EJY3: Molecular and Enzymatic Verification. Appl. Environ. Microbiol. 2020, 86, e02724-19. [Google Scholar] [CrossRef]
  48. Tsevelkhorloo, M.; Kim, S.H.; Kang, D.K.; Lee, C.R.; Hong, S.K. NADP+-Dependent Dehydrogenase SCO3486 and Cycloisomerase SCO3480: Key Enzymes for 3,6-Anhydro-L-Galactose Catabolism in Streptomyces coelicolor A3(2). J. Microbiol. Biotechnol. 2021, 31, 756–763. [Google Scholar] [CrossRef]
  49. Yun, E.J.; Lee, S.; Kim, H.T.; Pelton, J.G.; Kim, S.; Ko, H.J.; Choi, I.G.; Kim, K.H. The novel catabolic pathway of 36-anhydro-L-galactose the main component of red macroalgae in a marine bacterium. Environ. Microbiol. 2015, 17, 1677–1688. [Google Scholar] [CrossRef]
  50. Ra, C.H.; Kim, Y.J.; Lee, S.Y.; Jeong, G.T.; Kim, S.K. Effects of galactose adaptation in yeast for ethanol fermentation from red seaweed, Gracilaria verrucosa. Bioprocess Biosyst. Eng. 2015, 38, 1715–1722. [Google Scholar] [CrossRef]
  51. Jin, Y.; Yu, S.; Liu, J.J.; Yun, E.J.; Lee, J.W.; Jin, Y.S.; Kim, K.H. Production of neoagarooligosaccharides by probiotic yeast Saccharomyces cerevisiae var. boulardii engineered as a microbial cell factory. Microb. Cell Fact. 2021, 20, 160. [Google Scholar] [CrossRef] [PubMed]
  52. Singh, D.P.; Prabha, R.; Verma, S.; Meena, K.K.; Yandigeri, M. Antioxidant properties and polyphenolic content in terrestrial cyanobacteria. 3 Biotech 2017, 7, 134. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  53. Ren, B.; Wu, M.; Wang, Q.; Peng, X.; Wen, H.; McKinstry, W.J.; Chen, Q. Crystal structure of tannase from Lactobacillus plantarum. J. Mol. Biol. 2013, 425, 2737–2751. [Google Scholar] [CrossRef]
  54. Ragan, M.A.; Glombitza, K.W. Phlorotannins Brown Algal Polyphenols. Prog. Phycol. Res. 1986, 4, 129–241. [Google Scholar]
  55. Ahn, M.J.; Yoon, K.D.; Kim, C.Y.; Kim, J.H.; Shin, C.G.; Kim, J. Inhibitory activity on HIV-1 reverse transcriptase and integrase of a carmalol derivative from a brown Alga Ishige okamurae. Phytother. Res. 2006, 20, 711–713. [Google Scholar] [CrossRef]
  56. Singh, R.; Barden, A.; Mori, T.; Beilin, L. Advanced glycation end-products: A review. Diabetologia 2001, 44, 129–146. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  57. Izgilov, R.; Naftaly, A.; Benayahu, D. Advanced Glycation End Products Effects on Adipocyte Niche Stiffness and Cell Signaling. Int. J. Mol. Sci. 2023, 24, 2261. [Google Scholar] [CrossRef] [PubMed]
  58. Ahmed, N. Advanced glycation endproducts-role in pathology of diabetic complications. Diabetes Res. Clin. Pract. 2005, 67, 3–21. [Google Scholar] [CrossRef]
  59. Suzuki, A.; Yabu, A.; Nakamura, H. Advanced glycation end products in musculoskeletal system and disorders. Methods 2022, 203, 179–186. [Google Scholar] [CrossRef]
  60. Nilsson, B.O. Biological effects of aminoguanidine: An update. Inflamm. Res. 1999, 48, 509–515. [Google Scholar] [CrossRef]
  61. Kalousová, M.; Zima, T.; Tesar, V.; Stípek, S.; Sulková, S. Advanced glycation end products in clinical nephrology. Kidney Blood Press. Res. 2004, 27, 18–28. [Google Scholar] [CrossRef] [PubMed]
  62. Motta, B.P.; Kaga, A.K.; Oliveira, J.O.; Inacio, M.D.; da Silva, C.F.; de Sousa Junior, P.T.; Brunetti, I.L.; Baviera, A.M. In vitro inhibition of protein glycation and advanced glycation end products formation by hydroethanolic extract and two fractions of Simaba trichilioides roots. Nat. Prod. Res. 2020, 34, 2389–2393. [Google Scholar] [CrossRef] [PubMed]
  63. Schalkwijk, C.G.; Stehouwer, C.D.A. Methylglyoxal a Highly Reactive Dicarbonyl Compound in Diabetes Its Vascular Complications and Other Age-Related Diseases. Physiol. Rev. 2020, 100, 407–461. [Google Scholar] [CrossRef] [PubMed]
  64. Odani, H.; Shinzato, T.; Matsumoto, Y.; Usami, J.; Maeda, K. Increase in three alphabeta-dicarbonyl compound levels in human uremic plasma: Specific in vivo determination of intermediates in advanced Maillard reaction. Biochem. Biophys. Res. Commun. 1999, 256, 89–93. [Google Scholar] [CrossRef]
  65. Hanssen, N.M.J.; Teraa, M.; Scheijen, J.L.J.M.; Van de Waarenburg, M.; Gremmels, H.; Stehouwer, C.D.A.; Verhaar, M.C.; Schalkwijk, C.G. Plasma Methylglyoxal Levels Are Associated With Amputations and Mortality in Severe Limb Ischemia Patients With and Without Diabetes. Diabetes Care 2021, 44, 157–163. [Google Scholar] [CrossRef]
  66. Sugiura, S.; Minami, Y.; Taniguchi, R.; Tanaka, R.; Miyake, H.; Mori, T.; Ueda, M.; Shibata, T. Evaluation of Anti-glycation Activities of Phlorotannins in Human and Bovine Serum Albumin-methylglyoxal Models. Nat. Prod. Commun. 2017, 12, 1793–1796. [Google Scholar] [CrossRef] [Green Version]
  67. Yagi, M.; Yonei, Y. Glycative stress and anti-aging: 10. Glycative stress and liver disease. Glycative Stress Res. 2018, 5, 177–180. [Google Scholar]
  68. Ooi, H.; Nasu, R.; Furukawa, A.; Takeuchi, M.; Koriyama, Y. Pyridoxamine and Aminoguanidine Attenuate the Abnormal Aggregation of β-Tubulin and Suppression of Neurite Outgrowth by Glyceraldehyde-Derived Toxic Advanced Glycation End-Products. Front. Pharmacol. 2022, 13, 921611. [Google Scholar] [CrossRef]
  69. Dong, Z.; Iwata, D.; Kitaichi, N.; Takeuchi, M.; Sato, M.; Endo, N.; Iwabuchi, K.; Ando, R.; Fukuhara, J.; Kinoshita, S.; et al. Amelioration of experimental autoimmune uveoretinitis by inhibition of glyceraldehyde-derived advanced glycation end-product formation. J. Leukoc. Biol. 2014, 96, 1077–1085. [Google Scholar] [CrossRef]
  70. Takata, T.; Sakasai-Sakai, A.; Takeuchi, M. Impact of intracellular toxic advanced glycation end-products (TAGE) on murine myoblast cell death. Diabetol. Metab. Syndr. 2020, 12, 54. [Google Scholar] [CrossRef]
  71. Sugiura, S.; Tanaka, R.; Nishioka, Y.; Iwase, R.; Tanaka, R.; Miyake, H.; Mori, T.; Ueda, M.; Shibata, T. Evaluation of Anti-glycation Activities of Phlorotannins in Human and Bovine Serum Albumin-glyceraldehyde Models. Nat. Prod. Commun. 2018, 13, 1007–1010. [Google Scholar] [CrossRef] [Green Version]
  72. Ames, J.M. Determination of N epsilon-(carboxymethyl)lysine in foods and related systems. Ann. N. Y. Acad. Sci. 2008, 1126, 20–24. [Google Scholar] [CrossRef] [PubMed]
  73. Alikhani, M.; Maclellan, C.M.; Raptis, M.; Vora, S.; Trackman, P.C.; Graves, D.T. Advanced glycation end products induce apoptosis in fibroblasts through activation of ROS MAP kinases and the FOXO1 transcription factor. Am. J. Physiol. Cell Physiol. 2007, 292, C850-6. [Google Scholar] [CrossRef] [PubMed]
  74. Sroga, G.E.; Stephen, S.J.; Wang, B.; Vashishth, D. Techniques for advanced glycation end product measurements for diabetic bone disease: Pitfalls and future directions. Curr. Opin. Endocrinol. Diabetes Obes. 2022, 29, 333–342. [Google Scholar] [CrossRef]
  75. Khosravi, R.; Sodek, K.L.; Faibish, M.; Trackman, P.C. Collagen advanced glycation inhibits its Discoidin Domain Receptor 2 (DDR2)-mediated induction of lysyl oxidase in osteoblasts. Bone 2014, 58, 33–41. [Google Scholar] [CrossRef] [Green Version]
  76. Murata, N.; Azuma, M.; Yamauchi, K.; Miyake, H.; Tanaka, R.; Shibata, T. Phlorotannins Remarkably Suppress the Formation of Nε-(Carboxymethyl)lysine in a Collagen-Glyoxal Environment. Nat. Prod. Commun. 2020, 15, 1–6. [Google Scholar] [CrossRef]
  77. Sawabe, T.; Tanaka, R.; Iqbal, M.M.; Tajima, K.; Ezura, Y.; Ivanova, E.P.; Christen, R. Assignment of Alteromonas elyakovii KMM 162T and five strains isolated from spot-wounded fronds of Laminaria japonica to Pseudoalteromonas elyakovii comb. nov. and the extended description of the species. Int. J. Syst. Evol. Microbiol. 2000, 50 Pt 1, 265–271. [Google Scholar] [CrossRef]
  78. Ivanova, E.P.; Bakunina, I.Y.; Sawabe, T.; Hayashi, K.; Alexeeva, Y.V.; Zhukova, N.V.; Nicolau, D.V.; Zvaygintseva, T.N.; Mikhailov, V.V. Two species of culturable bacteria associated with degradation of brown algae Fucus evanescens. Microb. Ecol. 2002, 43, 242–249. [Google Scholar] [CrossRef]
  79. Tanaka, R.; Cleenwerck, I.; Mizutani, Y.; Iehata, S.; Shibata, T.; Miyake, H.; Mori, T.; Tamaru, Y.; Ueda, M.; Bossier, P.; et al. Formosa haliotis sp. nov. a brown-alga-degrading bacterium isolated from the gut of the abalone Haliotis gigantea. Int. J. Syst. Evol. Microbiol. 2015, 65, 4388–4393. [Google Scholar] [CrossRef]
  80. Tanaka, R.; Mizutani, Y.; Shibata, T.; Miyake, H.; Iehata, S.; Mori, T.; Kuroda, K.; Ueda, M. Genome Sequence of Formosa haliotis Strain MA1 a Brown Alga-Degrading Bacterium Isolated from the Gut of Abalone Haliotis gigantea. Genome Announc. 2016, 4, e01312-16. [Google Scholar] [CrossRef] [Green Version]
  81. Mori, T.; Takahashi, M.; Tanaka, R.; Miyake, H.; Shibata, T.; Chow, S.; Kuroda, K.; Ueda, M.; Takeyama, H. Falsirhodobacter sp. alg1 Harbors Single Homologs of Endo and Exo-Type Alginate Lyases Efficient for Alginate Depolymerization. PLoS ONE 2016, 11, e0155537. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  82. Yonemotov, Y.; Tanaka, H.; Hisano, T.; Sakaguchi, K.; Abe, S.; Yamashita, T.; Kimura, A.; Murata, K. Bacterial Alginate Lyase Gene—Nucleotide-Sequence and Molecular Route for Generation of Alginate Lyase Species. J. Ferment. Bioeng. 1993, 75, 336–342. [Google Scholar] [CrossRef]
  83. Thomas, F.; Barbeyron, T.; Tonon, T.; Genicot, S.; Czjzek, M.; Michel, G. Characterization of the first alginolytic operons in a marine bacterium: From their emergence in marine Flavobacteriia to their independent transfers to marine Proteobacteria and human gut Bacteroides. Environ. Microbiol. 2012, 14, 2379–2394. [Google Scholar] [CrossRef]
  84. Jagtap, S.S.; Hehemann, J.H.; Polz, M.F.; Lee, J.K.; Zhao, H. Comparative biochemical characterization of three exolytic oligoalginate lyases from Vibrio splendidus reveals complementary substrate scope temperature and pH adaptations. Appl. Environ. Microbiol. 2014, 80, 4207–4214. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  85. Ekborg, N.A.; Gonzalez, J.M.; Howard, M.B.; Taylor, L.E.; Hutcheson, S.W.; Weiner, R.M. Saccharophagus degradans gen. nov. sp. nov. a versatile marine degrader of complex polysaccharides. Int. J. Syst. Evol. Microbiol. 2005, 55 Pt 4, 1545–1549. [Google Scholar] [CrossRef] [Green Version]
  86. Mori, T.; Takahashi, M.; Tanaka, R.; Shibata, T.; Kuroda, K.; Ueda, M.; Takeyama, H. Draft Genome Sequence of Falsirhodobacter sp. Strain alg1 an Alginate-Degrading Bacterium Isolated from Fermented Brown Algae. Genome Announc. 2014, 2, e00826-14. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  87. Wargacki, A.J.; Leonard, E.; Win, M.N.; Regitsky, D.D.; Santos, C.N.; Kim, P.B.; Cooper, S.R.; Raisner, R.M.; Herman, A.; Sivitz, A.B.; et al. An engineered microbial platform for direct biofuel production from brown macroalgae. Science 2012, 335, 308–313. [Google Scholar] [CrossRef] [Green Version]
  88. Santos, C.N.S.; Regitsky, D.D.; Yoshikuni, Y. Implementation of stable and complex biological systems through recombinase-assisted genome engineering. Nat. Commun. 2013, 4, 2503. [Google Scholar] [CrossRef] [Green Version]
  89. Wang, D.M.; Kim, H.T.; Yun, E.J.; Kim, D.H.; Park, Y.C.; Woo, H.C.; Kim, K.H. Optimal production of 4-deoxy-L-erythro-5-hexoseulose uronic acid from alginate for brown macro algae saccharification by combining endo- and exo-type alginate lyases. Bioprocess Biosyst. Eng. 2014, 37, 2105–2111. [Google Scholar] [CrossRef]
  90. Tanaka, Y.; Murase, Y.; Shibata, T.; Tanaka, R.; Mori, T.; Miyake, H. Production of 4-Deoxy-L-erythro-5-Hexoseulose Uronic Acid Using Two Free and Immobilized Alginate Lyases from Falsirhodobacter sp. Alg1. Molecules 2022, 27, 3308. [Google Scholar] [CrossRef]
  91. Shibasaki, S.; Ueda, M. Therapeutic antibodies and other proteins obtained by molecular display technologies. Recent Pat. Biotechnol. 2009, 3, 19–27. [Google Scholar] [CrossRef] [PubMed]
  92. Shibasaki, S. Development of platform technology using molecular display. Yakugaku Zasshi 2009, 129, 1333–1340. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  93. Ueda, M. Establishment of cell surface engineering and its development. Biosci. Biotechnol. Biochem. 2016, 80, 1243–1253. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  94. Smith, G.P. Filamentous fusion phage: Novel expression vectors that display cloned antigens on the virion surface. Science 1985, 228, 1315–1317. [Google Scholar] [CrossRef] [PubMed]
  95. Scott, J.K.; Smith, G.P. Searching for peptide ligands with an epitope library. Science 1990, 249, 386–390. [Google Scholar] [CrossRef] [PubMed]
  96. Bozovičar, K.; Molek, P.; Bizjan, B.J.; Bratkovič, T. Ligand Selection for Affinity Chromatography Using Phage Display. Methods Mol. Biol. 2022, 2466, 159–185. [Google Scholar]
  97. Georgiou, G.; Poetschke, H.L.; Stathopoulos, C.; Francisco, J.A. Practical applications of engineering gram-negative bacterial cell surfaces. Trends Biotechnol. 1993, 11, 6–10. [Google Scholar] [CrossRef]
  98. Little, M.; Fuchs, P.; Breitling, F.; Dübel, S. Bacterial surface presentation of proteins and peptides: An alternative to phage technology? Trends Biotechnol. 1993, 11, 3–5. [Google Scholar] [CrossRef]
  99. Francisco, J.A.; Stathopoulos, C.; Warren, R.A.; Kilburn, D.G.; Georgiou, G. Specific adhesion and hydrolysis of cellulose by intact Escherichia coli expressing surface anchored cellulase or cellulose binding domains. Biotechnology 1993, 11, 491–495. [Google Scholar] [CrossRef]
  100. Krause, S.; Würdemann, D.; Wentzel, A.; Christmann, A.; Fehr, H.; Kolmar, H.; Friedrich, K. Bacteria displaying interleukin-4 mutants stimulate mammalian cells and reflect the biological activities of variant soluble cytokines. ChemBioChem 2004, 5, 804–810. [Google Scholar] [CrossRef]
  101. Bule, P.; Cameron, K.; Prates, J.A.M.; Ferreira, L.M.A.; Smith, S.P.; Gilbert, H.J.; Bayer, E.A.; Najmudin, S.; Fontes, C.M.G.A.; Alves, V.D. Structure-function analyses generate novel specificities to assemble the components of multienzyme bacterial cellulosome complexes. J. Biol. Chem. 2018, 293, 4201–4212. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  102. Kim, D.; Kim, W.; Kim, J. New Bacterial Surface Display System Development and Application Based on Bacillus subtilis YuaB Biofilm Component as an Anchoring Motif. Biotechnol. Bioprocess Eng. 2021, 26, 39–46. [Google Scholar] [CrossRef] [PubMed]
  103. Michon, C.; Langella, P.; Eijsink, V.G.; Mathiesen, G.; Chatel, J.M. Display of recombinant proteins at the surface of lactic acid bacteria: Strategies and applications. Microb. Cell Fact. 2016, 15, 70. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  104. Löfblom, J.; Rosenstein, R.; Nguyen, M.T.; Ståhl, S.; Götz, F. Staphylococcus carnosus: From starter culture to protein engineering platform. Appl. Microbiol. Biotechnol. 2017, 101, 8293–8307. [Google Scholar] [CrossRef] [Green Version]
  105. Lim, S.; Glasgow, J.E.; Filsinger Interrante, M.; Storm, E.M.; Cochran, J.R. Dual display of proteins on the yeast cell surface simplifies quantification of binding interactions and enzymatic bioconjugation reactions. Biotechnol. J. 2017, 12. [Google Scholar] [CrossRef] [Green Version]
  106. Shibasaki, S.; Ueda, M.; Ye, K.; Shimizu, K.; Kamasawa, N.; Osumi, M.; Tanaka, A. Creation of cell surface-engineered yeast that display different fluorescent proteins in response to the glucose concentration. Appl. Microbiol. Biotechnol. 2001, 57, 528–533. [Google Scholar]
  107. Ito, J.; Kosugi, A.; Tanaka, T.; Kuroda, K.; Shibasaki, S.; Ogino, C.; Ueda, M.; Fukuda, H.; Doi, R.H.; Kondo, A. Regulation of the display ratio of enzymes on the Saccharomyces cerevisiae cell surface by the immunoglobulin G and cellulosomal enzyme binding domains. Appl. Environ. Microbiol. 2009, 75, 4149–4154. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  108. Shibasaki, S.; Ueda, M.; Iizuka, T.; Hirayama, M.; Ikeda, Y.; Kamasawa, N.; Osumi, M.; Tanaka, A. Quantitative evaluation of the enhanced green fluorescent protein displayed on the cell surface of Saccharomyces cerevisiae by fluorometric and confocal laser scanning microscopic analyses. Appl. Microbiol. Biotechnol. 2001, 55, 471–475. [Google Scholar] [CrossRef]
  109. Shibasaki, S.; Ninomiya, Y.; Ueda, M.; Iwahashi, M.; Katsuragi, T.; Tani, Y.; Harashima, S.; Tanaka, A. Intelligent yeast strains with the ability to self-monitor the concentrations of intra- and extracellular phosphate or ammonium ion by emission of fluorescence from the cell surface. Appl. Microbiol. Biotechnol. 2001, 57, 702–707. [Google Scholar]
  110. Fleet, G.H. The Yeasts, 2nd ed.; Rose, A.H., Harrison, J.S., Eds.; Academic Press: Cambridge, MA, USA, 1991; Volume 4, p. 199. [Google Scholar]
  111. Kipnis, P.; Thomas, N.; Ovalle, R.; Lipke, P.N. The ER-Golgi v-SNARE Bet1p is required for cross-linking alpha-agglutinin to the cell wall in yeast. Microbiology 2004, 150 Pt 10, 3219–3228. [Google Scholar] [CrossRef] [Green Version]
  112. Lu, C.F.; Montijn, R.C.; Brown, J.L.; Klis, F.; Kurjan, J.; Bussey, H.; Lipke, P.N. Glycosyl phosphatidylinositol-dependent cross-linking of alpha-agglutinin and beta 1,6-glucan in the Saccharomyces cerevisiae cell wall. J. Cell Biol. 1995, 128, 333–340. [Google Scholar] [CrossRef] [PubMed]
  113. Shibasaki, S.; Tanaka, A.; Ueda, M. Development of combinatorial bioengineering using yeast cell surface display--order-made design of cell and protein for bio-monitoring. Biosens. Bioelectron. 2003, 19, 123–130. [Google Scholar] [CrossRef] [PubMed]
  114. Shibasaki, S.; Ueda, M. Development of yeast molecular display systems focused on therapeutic proteins enzymes and foods: Functional analysis of proteins and its application to bioconversion. Recent Pat. Biotechnol. 2010, 4, 198–213. [Google Scholar] [CrossRef] [PubMed]
  115. Shibasaki, S.; Aoki, W.; Nomura, T.; Miyoshi, A.; Tafuku, S.; Sewaki, T.; Ueda, M. An oral vaccine against candidiasis generated by a yeast molecular display system. Pathog. Dis. 2013, 69, 262–268. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  116. Shibasaki, S.; Karasaki, M.; Tafuku, S.; Aoki, W.; Sewaki, T.; Ueda, M. Oral Immunization Against Candidiasis Using Lactobacillus casei Displaying Enolase 1 from Candida albicans. Sci. Pharm. 2014, 82, 697–708. [Google Scholar] [CrossRef] [Green Version]
  117. Shibasaki, S.; Okada, J.; Nakayama, Y.; Yoshida, T.; Ueda, M. Isolation of bacteria which produce yeast cell wall-lytic enzymes and their characterization. Biocontrol Sci. 2008, 13, 91–96. [Google Scholar] [CrossRef] [Green Version]
  118. Adams, J.M.; Gallagher, J.A.; Donnison, I.S. Fermentation study on Saccharina latissima for bioethanol production considering variable pre-treatments. J. Appl. Phycol. 2009, 21, 569–574. [Google Scholar] [CrossRef]
  119. Lee, S.M.; Lee, J.H. The isolation and characterization of simultaneous saccharification and fermentation microorganisms for Laminaria japonica utilization. Bioresour. Technol. 2011, 102, 5962–5967. [Google Scholar] [CrossRef]
  120. Horn, S.J.; Aasen, I.M.; Ostgaard, K. Ethanol production from seaweed extract. J. Ind. Microbiol. Biotechnol. 2000, 25, 249–254. [Google Scholar] [CrossRef]
  121. Chujo, M.; Yoshida, S.; Ota, A.; Murata, K.; Kawai, S. Acquisition of the ability to assimilate mannitol by Saccharomyces cerevisiae through dysfunction of the general corepressor Tup1-Cyc8. Appl. Environ. Microbiol. 2015, 81, 9–16. [Google Scholar] [CrossRef] [Green Version]
  122. Motone, K.; Takagi, T.; Sasaki, Y.; Kuroda, K.; Ueda, M. Direct ethanol fermentation of the algal storage polysaccharide laminarin with an optimized combination of engineered yeasts. J. Biotechnol. 2016, 231, 129–135. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  123. Hutcheson, S.W.; Zhang, H.; Suvorov, M. Carbohydrase systems of Saccharophagus degradans degrading marine complex polysaccharides. Mar. Drugs 2011, 9, 645–665. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  124. Shibasaki, S.; Maeda, H.; Ueda, M. Molecular display technology using yeast--arming technology. Anal. Sci. 2009, 25, 41–49. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  125. Kondo, A.; Ueda, M. Yeast cell-surface display--applications of molecular display. Appl. Microbiol. Biotechnol. 2004, 64, 28–40. [Google Scholar] [CrossRef] [PubMed]
  126. Saha, B.C. Hemicellulose bioconversion. J. Ind. Microbiol. Biotechnol. 2003, 30, 279–291. [Google Scholar] [CrossRef]
  127. Katahira, S.; Fujita, Y.; Mizuike, A.; Fukuda, H.; Kondo, A. Construction of a xylan-fermenting yeast strain through codisplay of xylanolytic enzymes on the surface of xylose-utilizing Saccharomyces cerevisiae cells. Appl. Environ. Microbiol. 2004, 70, 5407–5414. [Google Scholar] [CrossRef] [Green Version]
  128. Eliasson, A.; Christensson, C.; Wahlbom, C.F.; Hahn-Hagerdal, B. Anaerobic xylose fermentation by recombinant Saccharomyces cerevisiae carrying XYL1 XYL2 and XKS1 in mineral medium chemostat cultures. Appl. Environ. Microbiol. 2000, 66, 3381–3386. [Google Scholar] [CrossRef] [Green Version]
  129. Matsushika, A.; Inoue, H.; Kodaki, T.; Sawayama, S. Ethanol production from xylose in engineered Saccharomyces cerevisiae strains: Current state and perspectives. Appl. Microbiol. Biotechnol. 2009, 84, 37–53. [Google Scholar] [CrossRef]
  130. Kim, D.M.; Choi, S.H.; Ko, B.S.; Jeong, G.Y.; Jang, H.B.; Han, J.G.; Jeong, K.H.; Lee, H.Y.; Won, Y.; Kim, I.C. Reduction of PDC1 expression in S. cerevisiae with xylose isomerase on xylose medium. Bioprocess Biosyst. Eng. 2012, 35, 183–189. [Google Scholar] [CrossRef]
  131. Usvalampi, A.; Turunen, O.; Valjakka, J.; Pastinen, O.; Leisola, M.; Nyyssölä, A. Production of L-xylose from L-xylulose using Escherichia coli L-fucose isomerase. Enzyme Microb. Technol. 2012, 50, 71–76. [Google Scholar] [CrossRef]
  132. Lee, S.M.; Jellison, T.; Alper, H.S. Directed evolution of xylose isomerase for improved xylose catabolism and fermentation in the yeast Saccharomyces cerevisiae. Appl. Environ. Microbiol. 2012, 78, 5708–5716. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  133. Ota, M.; Sakuragi, H.; Morisaka, H.; Kuroda, K.; Miyake, H.; Tamaru, Y.; Ueda, M. Display of Clostridium cellulovorans xylose isomerase on the cell surface of Saccharomyces cerevisiae and its direct application to xylose fermentation. Biotechnol. Prog. 2013, 29, 346–351. [Google Scholar] [CrossRef] [PubMed]
  134. Chiang, L.C.; Gong, C.S.; Chen, L.F.; Tsao, G.T. D-Xylulose fermentation to ethanol by Saccharomyces cerevisiae. Appl. Environ. Microbiol. 1981, 42, 284–289. [Google Scholar] [CrossRef] [Green Version]
  135. Chu, B.C.H.; Lee, H. Genetic improvement of Saccharomyces cerevisiae for xylose fermentation. Biotechnol. Adv. 2007, 25, 425–441. [Google Scholar] [CrossRef] [PubMed]
  136. Hartley, B.S.; Hanlon, N.; Jackson, R.J.; Rangarajan, M. Glucose isomerase: Insights into protein engineering for increased thermostability. Biochim. Biophys. Acta 2000, 1543, 294–335. [Google Scholar] [CrossRef]
  137. Sasaki, Y.; Takagi, T.; Motone, K.; Kuroda, K.; Ueda, M. Enhanced direct ethanol production by cofactor optimization of cell surface-displayed xylose isomerase in yeast. Biotechnol. Prog. 2017, 33, 1068–1076. [Google Scholar] [CrossRef]
  138. Weiner, R.M.; Taylor, L.E., II; Henrissat, B.; Hauser, L.; Land, M.; Coutinho, P.M.; Rancurel, C.; Saunders, E.H.; Longmire, A.G.; Zhang, H.; et al. Complete genome sequence of the complex carbohydrate-degrading marine bacterium Saccharophagus degradans strain 2-40 T. PLoS Genet. 2008, 4, e1000087. [Google Scholar] [CrossRef] [Green Version]
  139. Selig, M.J.; Knoshaug, E.P.; Decker, S.R.; Baker, J.O.; Himmel, M.E.; Adney, W.S. Heterologous expression of Aspergillus niger beta-D-xylosidase (XlnD): Characterization on lignocellulosic substrates. Appl. Biochem. Biotechnol. 2008, 146, 57–68. [Google Scholar] [CrossRef]
  140. Nerinckx, W.; Broberg, A.; Duus, J.O.; Ntarima, P.; Parolis, L.A.; Parolis, H.; Claeyssens, M. Hydrolysis of Nothogenia erinacea xylan by xylanases from families 10 and 11. Carbohydr. Res. 2004, 339, 1047–1060. [Google Scholar] [CrossRef]
  141. Enquist-Newman, M.; Faust, A.M.E.; Bravo, D.D.; Santos, C.N.S.; Raisner, R.M.; Hanel, A.; Sarvabhowman, P.; Le, C.; Regitsky, D.D.; Cooper, S.R.; et al. Efficient ethanol production from brown macroalgae sugars by a synthetic yeast platform. Nature 2014, 505, 239–243. [Google Scholar] [CrossRef]
  142. Takagi, T.; Yokoi, T.; Shibata, T.; Morisaka, H.; Kuroda, K.; Ueda, M. Engineered yeast whole-cell biocatalyst for direct degradation of alginate from macroalgae and production of non-commercialized useful monosaccharide from alginate. Appl. Microbiol. Biotechnol. 2016, 100, 1723–1732. [Google Scholar] [CrossRef] [PubMed]
  143. Takagi, T.; Sasaki, Y.; Motone, K.; Shibata, T.; Tanaka, R.; Miyake, H.; Mori, T.; Kuroda, K.; Ueda, M. Construction of bioengineered yeast platform for direct bioethanol production from alginate and mannitol. Appl. Microbiol. Biotechnol. 2017, 101, 6627–6636. [Google Scholar] [CrossRef]
  144. Bae, J.; Kuroda, K.; Ueda, M. Proximity effect among cellulose-degrading enzymes displayed on the Saccharomyces cerevisiae cell surface. Appl. Environ. Microbiol. 2015, 81, 59–66. [Google Scholar] [CrossRef] [Green Version]
  145. Sasaki, Y.; Takagi, T.; Motone, K.; Shibata, T.; Kuroda, K.; Ueda, M. Direct bioethanol production from brown macroalgae by co-culture of two engineered Saccharomyces cerevisiae strains. Biosci. Biotechnol. Biochem. 2018, 82, 1459–1462. [Google Scholar] [CrossRef] [PubMed]
  146. Kawai, S.; Murata, K. Biofuel production based on carbohydrates from both brown and red macroalgae: Recent developments in key biotechnologies. Int. J. Mol. Sci. 2016, 17, 145. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  147. Iwao, T.; Kurashima, A.; Maegawa, M. Effect of seasonal changes in the photosynthates mannitol and laminaran on maturation of Ecklonia cava (Phaeophyceae, Laminariales) in Nishiki Bay central Japan. Phycol. Res. 2008, 56, 1–6. [Google Scholar] [CrossRef]
  148. Kwak, I.S.; Won, S.W.; Chung, Y.S.; Yun, Y.S. Ruthenium recovery from acetic acid waste water through sorption with bacterial biosorbent fibers. Bioresour. Technol. 2013, 128, 30–35. [Google Scholar] [CrossRef]
  149. Kato, Y.; Kimura, S.; Kogure, T.; Suzuki, M. Deposition of Lead Phosphate by Lead-Tolerant Bacteria Isolated from Fresh Water near an Abandoned Mine. Int. J. Mol. Sci. 2022, 23, 2483. [Google Scholar] [CrossRef]
  150. Syed, Z.; Sogani, M.; Rajvanshi, J.; Sonu, K. Microbial Biofilms for Environmental Bioremediation of Heavy Metals: A Review. Appl. Biochem. Biotechnol. 2022. [Google Scholar] [CrossRef]
  151. Wang, Z.; Wang, H.; Nie, Q.; Ding, Y.; Lei, Z.; Zhang, Z.; Shimizu, K.; Yuan, T. Pb(II) bioremediation using fresh algal-bacterial aerobic granular sludge and its underlying mechanisms highlighting the role of extracellular polymeric substances. J. Hazard. Mater. 2023, 444 Pt B, 130452. [Google Scholar] [CrossRef]
  152. Carreira, A.R.F.; Veloso, T.; Macário, I.P.E.; Pereira, J.L.; Ventura, S.P.M.; Passos, H.; Coutinho, J.A.P. The role of biomass elemental composition and ion-exchange in metal sorption by algae. Chemosphere 2023, 314, 137675. [Google Scholar] [CrossRef]
  153. Figueira, P.; Henriques, B.; Teixeira, A.; Lopes, C.B.; Reis, A.T.; Monteiro, R.J.; Duarte, A.C.; Pardal, M.A.; Pereira, E. Comparative study on metal biosorption by two macroalgae in saline waters: Single and ternary systems. Environ. Sci. Pollut. Res. Int. 2016, 23, 11985–11997. [Google Scholar] [CrossRef] [PubMed]
  154. Fernando, I.P.S.; Sanjeewa, K.K.A.; Kim, S.Y.; Lee, J.S.; Jeon, Y.J. Reduction of heavy metal (Pb2+) biosorption in zebrafish model using alginic acid purified from Ecklonia cava and two of its synthetic derivatives. Int. J. Biol. Macromol. 2018, 106, 330–337. [Google Scholar] [CrossRef] [PubMed]
  155. Milinovic, J.; Vale, C.; Botelho, M.J.; Pereira, E.; Sardinha, J.; Murton, B.J.; Noronha, J.P. Selective incorporation of rare earth elements by seaweeds from Cape Mondego western Portuguese coast. Sci. Total Environ. 2021, 795, 148860. [Google Scholar] [CrossRef] [PubMed]
  156. Fabre, E.; Dias, M.; Costa, M.; Henriques, B.; Vale, C.; Lopes, C.B.; Pinheiro-Torres, J.; Silva, C.M.; Pereira, E. Negligible effects of potentially toxic elements and rare earth elements on mercury removal from contaminated waters by green brown and red living marine macroalgae. Sci. Total Environ. 2020, 724, 138133. [Google Scholar] [CrossRef]
  157. Ferreira, N.; Ferreira, A.; Viana, T.; Lopes, C.B.; Costa, M.; Pinto, J.; Soares, J.; Pinheiro-Torres, J.; Henriques, B.; Pereira, E. Assessment of marine macroalgae potential for gadolinium removal from contaminated aquatic systems. Sci. Total Environ. 2020, 749, 141488. [Google Scholar] [CrossRef]
  158. Ownsworth, E.; Selby, D.; Ottley, C.J.; Unsworth, E.; Raab, A.; Feldmann, J.; Sproson, A.D.; Kuroda, J.; Faidutti, C.; Bücker, P. Tracing the natural and anthropogenic influence on the trace elemental chemistry of estuarine macroalgae and the implications for human consumption. Sci. Total Environ. 2019, 685, 259–272. [Google Scholar] [CrossRef] [Green Version]
  159. Kuroda, K.; Ueda, M. Engineering of microorganisms towards recovery of rare metal ions. Appl. Microbiol. Biotechnol. 2010, 87, 53–60. [Google Scholar] [CrossRef]
  160. Shibasaki, S.; Ueda, M. Bioadsorption strategies with yeast molecular display technology. Biocontrol Sci. 2014, 19, 157–164. [Google Scholar] [CrossRef] [Green Version]
  161. Kuroda, K.; Shibasaki, S.; Ueda, M.; Tanaka, A. Cell surface-engineered yeast displaying a histidine oligopeptide (hexa-His) has enhanced adsorption of and tolerance to heavy metal ions. Appl. Microbiol. Biotechnol. 2001, 57, 697–701. [Google Scholar] [CrossRef]
  162. Kuroda, K.; Ueda, M. Bioadsorption of cadmium ion by cell surface-engineered yeasts displaying metallothionein and hexa-His. Appl. Microbiol. Biotechnol. 2003, 63, 182–186. [Google Scholar] [CrossRef] [PubMed]
  163. Kuroda, K.; Ueda, M.; Shibasaki, S.; Tanaka, A. Cell surface-engineered yeast with ability to bind and self-aggregate in response to copper ion. Appl. Microbiol. Biotechnol. 2002, 59, 259–264. [Google Scholar]
  164. Kuroda, K.; Ueda, M. Effective display of metallothionein tandem repeats on the bioadsorption of cadmium ion. Appl. Microbiol. Biotechnol. 2006, 70, 458–463. [Google Scholar] [CrossRef] [PubMed]
  165. Nishitani, T.; Shimada, M.; Kuroda, K.; Ueda, M. Molecular design of yeast cell surface for adsorption and recovery of molybdenum one of rare metals. Appl. Microbiol. Biotechnol. 2010, 86, 641–648. [Google Scholar] [CrossRef]
  166. Kuroda, K.; Ebisutani, K.; Iida, K.; Nishitani, T.; Ueda, M. Enhanced adsorption and recovery of uranyl ions by NikR mutant-displaying yeast. Biomolecules 2014, 4, 390–401. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  167. Motone, K.; Takagi, T.; Aburaya, S.; Miura, N.; Aoki, W.; Ueda, M. A Zeaxanthin-Producing Bacterium Isolated from the Algal Phycosphere Protects Coral Endosymbionts from Environmental Stress. mBio 2020, 11, e01019-19. [Google Scholar] [CrossRef] [Green Version]
Figure 1. Examples of chemical structures of the saccharides in macroalgae. (A) Chain form (upper) and monomeric unit (lower) of alginate. (B) Laminarin. (C) Mannitol.
Figure 1. Examples of chemical structures of the saccharides in macroalgae. (A) Chain form (upper) and monomeric unit (lower) of alginate. (B) Laminarin. (C) Mannitol.
Microorganisms 11 01499 g001
Figure 2. Coculture system designed for xylan saccharification and ethanol fermentation. The system is based on both xylanase-displaying strains and xylose isomerase-displaying strains. Xylan is degraded to D-xylose by the Xyn11B- and XlnD-codisplaying strain. This figure has been adapted from a previous study [137].
Figure 2. Coculture system designed for xylan saccharification and ethanol fermentation. The system is based on both xylanase-displaying strains and xylose isomerase-displaying strains. Xylan is degraded to D-xylose by the Xyn11B- and XlnD-codisplaying strain. This figure has been adapted from a previous study [137].
Microorganisms 11 01499 g002
Figure 3. The cell surface display for direct bioethanol production from alginate and mannitol.
Figure 3. The cell surface display for direct bioethanol production from alginate and mannitol.
Microorganisms 11 01499 g003
Figure 4. Direct ethanol production from alginate and mannitol using the alginate- and mannitol-assimilating strain. This figure has been adapted from a previous study [143].
Figure 4. Direct ethanol production from alginate and mannitol using the alginate- and mannitol-assimilating strain. This figure has been adapted from a previous study [143].
Microorganisms 11 01499 g004
Table 1. IC50 values of crude phlorotannins against fluorescent AGEs formation [66].
Table 1. IC50 values of crude phlorotannins against fluorescent AGEs formation [66].
Algae (Original Area)HAS-MGO (mg/mL)BSA-MGO (mg/mL)
Eck. Cava (Mie)0.530.51
Eck. Kurome (Fukuoka)0.450.46
Eck. Kurome (Kumamoto)0.530.50
Cultured Eck. Kurome (Kumamoto)0.460.46
Eck. Stolonifera (Yamaguchi)0.520.47
Eis. arborea (Mie)0.460.53
Eis. bicyclis (Fukuoka)0.450.43
The values of aminoguanidine hydrochloride (positive controls) were 0.70 mg/mL in the HSA-MGO model and 0.90 mg/mL in the BSA-MGO model.
Table 2. IC50 values of crude phlorotannins against fluorescent AGEs formation [71].
Table 2. IC50 values of crude phlorotannins against fluorescent AGEs formation [71].
Algae (Original Area)HAS-GA (mg/mL)BSA-GA (mg/mL)
Eck. Cava (Mie)0.700.75
Eck. Kurome (Fukuoka)0.580.55
Eck. Kurome (Kumamoto)0.610.59
Cultured Eck. Kurome (Kumamoto)0.520.58
Eck. Stolonifera (Yamaguchi)0.540.56
Eis. arborea (Mie)0.510.61
Eis. bicyclis (Fukuoka)0.480.52
The values of aminoguanidine hydrochloride (positive controls) were 1.10 mg/mL in the HSA-GA model and 1.93 mg/mL in the BSA-GA model.
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Shibasaki, S.; Ueda, M. Utilization of Macroalgae for the Production of Bioactive Compounds and Bioprocesses Using Microbial Biotechnology. Microorganisms 2023, 11, 1499. https://doi.org/10.3390/microorganisms11061499

AMA Style

Shibasaki S, Ueda M. Utilization of Macroalgae for the Production of Bioactive Compounds and Bioprocesses Using Microbial Biotechnology. Microorganisms. 2023; 11(6):1499. https://doi.org/10.3390/microorganisms11061499

Chicago/Turabian Style

Shibasaki, Seiji, and Mitsuyoshi Ueda. 2023. "Utilization of Macroalgae for the Production of Bioactive Compounds and Bioprocesses Using Microbial Biotechnology" Microorganisms 11, no. 6: 1499. https://doi.org/10.3390/microorganisms11061499

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop